Q2 2025 · 13F-HR
Tetragon Partners GP Ltdholdings as filed
Filed 2025-08-14 · accession 0000902664-25-003596
$620.8M
Reported value
37
Positions
2025-06-30
Period end
The Brief · Tetragon Partners GP Ltd · Q2 2025
AI · grounded in 13F
Tetragon Partners GP Ltd established a new position in PATH valued at $175.6M. The fund also initiated new stakes in ALIBABA GROUP HLDG LTD [[stock:BABA 0.5 06/01/31]] for $127.7M and ISHARES TR HYG for $71.8M. Other new additions include KOLIBRI GLOBAL ENERGY INC KGEI and AUTOLUS THERAPEUTICS PLC AUTL.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 90364P105 | PATH | UIPATH INC | $175.6M | 28.3% | 13,722,244 | Common | SHARED |
| 01609WBG6 | BABA 0.5 06/01/31 | ALIBABA GROUP HLDG LTD | $127.7M | 20.6% | 100,000,000 | Common | SHARED |
| 464288513 | HYG | ISHARES TR | $66.3M | 10.7% | 822,000 | PUT | SHARED |
| 50043K406 | KGEI | KOLIBRI GLOBAL ENERGY INC | $48.7M | 7.84% | 7,068,857 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $21.7M | 3.49% | 9,500,000 | Common | SHARED |
| 47215PAJ5 | JD 0.25 06/01/29 | JD.COM INC | $20.9M | 3.36% | 20,000,000 | Common | SHARED |
| 85208T107 | CXM | SPRINKLR INC | $18.6M | 3.00% | 2,200,000 | Common | SHARED |
| 55087P104 | LYFT | LYFT INC | $15.8M | 2.54% | 1,000,000 | Common | SHARED |
| 53680QAA6 | LARCN 1.75 01/15/27 | LITHIUM ARGENTINA AG | $14.1M | 2.27% | 16,609,000 | Common | SHARED |
| 67421JAC2 | OTLY 9.25 09/14/28 | OATLY GROUP AB | $14.0M | 2.26% | 20,020,027 | Common | SHARED |
| 89677QAB3 | TCOM 0.75 06/15/29 | TRIP COM GROUP LTD | $11.1M | 1.79% | 10,000,000 | Common | SHARED |
| 98139A105 | WK | WORKIVA INC | $10.3M | 1.65% | 150,000 | Common | SHARED |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $10.1M | 1.63% | 250,000 | Common | SHARED |
| 32076VAD5 | AGCN 0.375 01/15/27 | FIRST MAJESTIC SILVER CORP | $7.3M | 1.17% | 7,500,000 | Common | SHARED |
| 03589W102 | ANNX | ANNEXON INC | $6.7M | 1.09% | 2,810,000 | Common | SHARED |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $6.4M | 1.04% | 316,150 | Common | SHARED |
| 464288513 | HYG | ISHARES TR | $5.5M | 0.89% | 68,660 | Common | SHARED |
| 23282WAC4 | CYTK 3.5 07/01/27 | CYTOKINETICS INC | $5.4M | 0.87% | 5,000,000 | Common | SHARED |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $4.5M | 0.73% | 228,832 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $4.3M | 0.70% | 41,531 | Common | SHARED |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.7M | 0.59% | 103,482 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.5M | 0.56% | 161,396 | Common | SHARED |
| N69605108 | PHVS | PHARVARIS N V | $3.3M | 0.53% | 188,100 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.4M | 0.39% | 699,000 | Common | SHARED |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.4M | 0.38% | 147,817 | Common | SHARED |
| 833445109 | SNOW | SNOWFLAKE INC | $2.2M | 0.36% | 10,000 | Common | SHARED |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.7M | 0.28% | 128,000 | Common | SHARED |
| 13321L108 | CCJ | CAMECO CORP | $1.4M | 0.23% | 19,280 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $1.4M | 0.23% | 218,750 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $1.3M | 0.21% | 138,375 | Common | SHARED |
| 443628102 | HBM | HUDBAY MINERALS INC | $1.1M | 0.18% | 107,000 | Common | SHARED |
| G01767105 | ALKS | ALKERMES PLC | $447,232 | 0.07% | 15,632 | Common | SHARED |
| 833635105 | SQM | SOCIEDAD QUIMICA Y MINERA DE | $271,579 | 0.04% | 7,700 | Common | SHARED |
| 878742204 | TECK | TECK RESOURCES LTD | $257,140 | 0.04% | 6,368 | Common | SHARED |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $190,384 | 0.03% | 115,384 | Common | SHARED |
| Y2066G138 | DSX/WS | DIANA SHIPPING INC | $24,096 | 0.00% | 301,200 | Common | SHARED |
| 83542D110 | SONWQ | SONDER HOLDINGS INC | $178 | 0.00% | 18,898 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.